| Literature DB >> 28536656 |
Juan Abel Ramírez Estudillo1, Mario Isaías León Higuera2, Sergio Rojas Juárez1, Maria de Lourdes Ordaz Vera3, Yessica Pablo Santana3, Benito Celis Suazo1.
Abstract
BACKGROUND: Age-related macular degeneration (AMD) is the leading cause of blindness in the western world. As a consequence of AMD, patients develop structural damage that comprises the fovea and subsequently present loss of central vision, low visual acuity and unstable fixation. Contrary to what happens with anti-angiogenic treatment in neovascular AMD, there is currently no definitive treatment to reverse geographic atrophy progression. The aim of this study was to determine the effectiveness of the visual rehabilitation treatment via microperimetry in patients with geographic atrophy.Entities:
Keywords: Age-related macular degeneration; Fixation stability; Geographic atrophy; Microperimetry; Visual rehabilitation
Year: 2017 PMID: 28536656 PMCID: PMC5439132 DOI: 10.1186/s40942-017-0071-1
Source DB: PubMed Journal: Int J Retina Vitreous ISSN: 2056-9920
Fig. 1Right eye microperimetry. Stable extra-foveal fixation with good sensitivity area (green zone) in a patient with myopic maculopathy
Fig. 2Microperimetry report. Sensitivity map and fixation areas as well as normative scales expressed in colors. Look at extra-foveal fixation used by the patient
Fig. 3Sensitivity map. Based on this map, the selection of PRT (dark blue dot) is done. The patient is trained in order to direct its fixation to the dark blue dot. The light blue dot is the PRL, which corresponds to the average of fixation points used by the patient
Fig. 4Change of fixation area used by the patient after training sessions
Fig. 5a Sensitivity map before training where it can be observed the difficulty in the fixation, PRT is selected in the area where sensitivity is observed. Large ellipse corresponds to 95% BCEA. b Trained fixation during training sessions. c New sensitivity map after rehabilitation, the same evaluated area as (a)
Basal characteristics
| Patient | Sex | Age | V.A. eye to treat | V.A. other eye |
|---|---|---|---|---|
| 1 | F | 70 | 0.4 | 0.4 |
| 2 | F | 77 | 0.4 | 2.1 |
| 3 | F | 85 | 0.4 | 1 |
| 4 | F | 77 | 1.1 | 1 |
| 5 | M | 74 | 1 | 1.4 |
| 6 | M | 68 | 0.7 | 1.3 |
| 7 | F | 69 | 0.6 | 1 |
| 8 | F | 65 | 0 | 1.9 |
| 9 | F | 73 | 1 | 1 |
| 10 | F | 75 | 0.6 | 1.3 |
| 11 | M | 92 | 1.1 | 1.4 |
| 12 | F | 82 | 0.5 | 0.8 |
| 13 | F | 91 | 1.1 | 2.1 |
| 14 | F | 67 | 0.2 | 0.6 |
| 15 | F | 73 | 1.5 | 1.6 |
| 16 | F | 75 | 0.5 | 0.7 |
| 17 | F | 89 | 0.6 | 1.4 |
| 18 | F | 82 | 0.3 | 1.3 |
V.A. visual acuity in LogMAR scale, M male, F female
Visual acuity and reading speed
| Patient | Initial V.A. | Final V.A. | Initial reading speed* | Final reading speed* |
|---|---|---|---|---|
| 1 | 0.4 | 0.4 | 38 | 68 |
| 2 | 0.4 | 0.3 | 98 | 110 |
| 3 | 0.4 | 0.2 | 64 | 54 |
| 4 | 1.1 | 1.1 | 57 | 48 |
| 5 | 1 | 1.1 | 65 | 41 |
| 6 | 0.7 | 0.5 | 80 | 228 |
| 7 | 0.6 | 0.5 | NA | NA |
| 8 | 0 | 0 | NA | NA |
| 9 | 1 | 0.8 | 41 | 72 |
| 10 | 0.6 | 0.5 | 0 | 46 |
| 11 | 1.1 | 1 | 37 | 103 |
| 12 | 0.5 | 0.5 | 42 | 61 |
| 13 | 1.1 | 1.1 | 40 | 68 |
| 14 | 0.2 | 0.1 | NA | NA |
| 15 | 1.5 | 1.3 | 0 | 0 |
| 16 | 0.5 | 0.5 | NA | NA |
| 17 | 0.6 | 0.6 | 51 | 36 |
| 18 | 0.3 | 0.3 | 53 | 31 |
V.A visual acuity in LogMAR scale, NA not available information
* Reading speed with both eyes (Mn read test) in words per minute
Fixation capacity and retinal sensitivity
| Patient | Initial P1 | Final P1 | Initial 95% BCEA | Final 95% BCEA | Initial threshold* | Final threshold* |
|---|---|---|---|---|---|---|
| 1 | 60 | 50 | 10.7 | 12.9 | 22.3 | 19.6 |
| 2 | 92 | 92 | 3.0 | 2.8 | 6.9 | 8.5 |
| 3 | 92 | 97 | 3.5 | 1.4 | 15.9 | 15.6 |
| 4 | 54 | 55 | 14.1 | 12.5 | 20.1 | 21.3 |
| 5 | 14 | 27 | 71.1 | 29.1 | 15.6 | 11.6 |
| 6 | 72 | 93 | 8.3 | 3.1 | 19.2 | 21.8 |
| 7 | 6 | 17 | 130.2 | 72.1 | 18.3 | 17.6 |
| 8 | 87 | 73 | 7.5 | 11.5 | 12.3 | 12.5 |
| 9 | 34 | 36 | 25.3 | 30.5 | 14.9 | 12.9 |
| 10 | 36 | 66 | 25.8 | 7.9 | 20.6 | 21 |
| 11 | 11 | 37 | 92.1 | 17.7 | 9.2 | 13.2 |
| 12 | 9 | 22 | 117.8 | 50.4 | 10.9 | 11.9 |
| 13 | 16 | 14 | 53.3 | 52.3 | 13.1 | 14.2 |
| 14 | 84 | 87 | 5.2 | 3.8 | 17.9 | 18.8 |
| 15 | 17 | 13 | 56.6 | 59.6 | 6.9 | 9.7 |
| 16 | 81 | 78 | 7.7 | 10.2 | 7.9 | 9.9 |
| 17 | 10 | 33 | 122.7 | 37.3 | 8.9 | 10.9 |
| 18 | 36 | 30 | 22.7 | 29.8 | 14.1 | 11.8 |
P1: expresses in percentage the number of fixation points that are within the area of a circle with 1-degree diameter. 95% BCEA (Bivariate Contour Ellipse Area) value establishes the ellipse area, expressed in square degrees, comprising 95% of the fixations points used by the patient during the test
* Average retinal sensitivity threshold in decibels
Mean values and statistical significance
| Mean | SD (±) |
| |
|---|---|---|---|
| Initial visual acuity | 0.7 LogMAR | 0.4 | 0.006 |
| Final visual acuity | 0.6 LogMAR | 0.4 | |
| initial reading speed | 47 wpm | 26 | 0.04 |
| Final reading speed | 69 wpm | 54 | |
| Initial retinal sensitivity | 14.1 dB | 4.9 | 0.4 |
| Final retinal sensitivity | 14.6 dB | 4.3 | |
| Initial P1 | 45% | 32 | 0.05 |
| Final P1 | 51% | 29 | |
| Initial 95% BCEA | 43° | 44 | 0.02 |
| Final 95% BCEA | 25° | 21 |
All data included refers to the treated eye, except for the reading speed, which was with both eyes
wpm words per minute, dB decibels, SD standard deviation